Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide‐induced tumour necrosis factor‐α generation
Data up to Jan 2025
Total Citations Per Year
Abstract
References (59)
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
1994 • 1,729 citations
Pharmacologic Analysis of Drug Receptor Interaction
1988 • 936 citations
Cloning and expression of cDNA for a human thromboxane A2 receptor
1991 • 680 citations
Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity
1993 • 546 citations
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype.
1993 • 475 citations
Cloning and expression of a cDNA for the human prostanoid FP receptor.
1994 • 386 citations
Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists.
1992 • 385 citations
Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
1994 • 384 citations
Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor.
1993 • 381 citations
Molecular Cloning and Characterization of the Human Prostanoid DP Receptor
1995 • 332 citations
Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype.
1993 • 305 citations
Studies of the characterisation of prostanoid receptors: A proposed classification
1982 • 305 citations
A novel inhibitory prostanoid receptor in piglet saphenous vein
1994 • 273 citations
Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype.
1994 • 244 citations
Cloning and expression of a cDNA for the human prostanoid IP receptor.
1994 • 187 citations
Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues
1986 • 167 citations
Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea‐pig ileum
1992 • 154 citations
Prostanoid receptors — the development of a working classification
1984 • 150 citations
Characterization of prostanoid relaxant/inhibitory receptors (ψ) using a highly selective agonist, TR4979
1986 • 149 citations
Cloning and Expression of the EP2 Subtype of Human Receptors for Prostaglandin E2
1993 • 144 citations
Quantifying Proliferation of Cultured Human and Rabbit Airway Smooth Muscle Cells in Response to Serum and Platelet-derived Growth Factor
1992 • 138 citations
Identification of prostaglandin E receptor ‘EP2’ cloned from mastocytoma cells as EP4 subtype
1995 • 137 citations
Characterization of cAMP-dependent inhibition of LPS-induced TNFα production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor
1994 • 136 citations
Regulation of cyclic AMP metabolism in rabbit cortical collecting tubule cells by prostaglandins.
1988 • 132 citations
Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
1995 • 129 citations
Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
1995 • 129 citations
Isoforms of the EP3 Subtype of Human Prostaglandin E2 Receptor Transduce Both Intracellular Calcium and cAMP Signals
1994 • 122 citations
Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP
1989 • 121 citations
Ligand binding to thromboxane receptors on human platelets: correlation with biological activity
1983 • 111 citations
Focus on prostacyclin and its novel mimetics
1996 • 109 citations
6-isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist
1995 • 108 citations
Prostacyclin analogs suppress the synthesis of tumor necrosis factor-α in LPS-stimulated human peripheral blood mononuclear cells
1993 • 102 citations
Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini
1994 • 100 citations
Potent contractile actions of prostanoid EP3‐receptor agonists on human isolated pulmonary artery
1994 • 92 citations
AH6809, a prostaglandin DP‐receptor blocking drug on human platelets
1988 • 90 citations
Investigation of the prostaglandin E (EP‐) receptor subtype mediating relaxation of the rabbit jugular vein
1992 • 87 citations
New evidence with selective agonists and antagonists for the subclassification of PGE2-sensitive (EP) receptors.
1987 • 85 citations
Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids
1995 • 80 citations
Cloning and Expression of the EP3-Subtype of Human Receptors for Prostaglandin E2
1994 • 75 citations
Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat
1986 • 73 citations
Cloning and expression of a prostaglandin E receptor EP3 subtype from human erythroleukaemia cells
1994 • 65 citations
A molecular analysis of PGE receptor (EP) expression on normal and transformed B lymphocytes: Coexpression of EP1, EP2, EP3β and EP4
1996 • 57 citations
Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery
1996 • 56 citations
AH13205, A Selective Prostanoid EP2‐receptor Agonist
1993 • 50 citations
Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: Probable involvement of EP3 receptors
1992 • 47 citations
Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3‐ and DP‐receptors
1994 • 40 citations
Exclusive expression of the Gs‐linked prostaglandin E2 receptor subtype 4 mRNA in human mononuclear Jurkat and KM‐3 cells and coexpression of subtype 4 and 2 mRNA in U‐937 cells
1996 • 40 citations
Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1 beta in human monocytic THP-1 cells.
1994 • 32 citations
Prejunctional prostanoid receptors on cardiac adrenergic terminals belong to the EP3 subtype
1991 • 29 citations
Characterization of prostanoid receptors on rat neutrophils
1994 • 29 citations
Characterization of the prostaglandin E2 sensitive (EP)‐receptor in the rat isolated trachea
1994 • 28 citations
Independent down-regulation of EP2 and EP3 subtypes of the prostaglandin E2 receptors on U937 human monocytic cells.
1995 • 28 citations
Characterization of the prostanoid receptors mediating inhibition of PAF‐induced aggregation of guinea‐pig eosinophils
1997 • 24 citations
An EP receptor with a novel pharmacological profile in the T‐cell line Jurkat
1995 • 24 citations
Comparison of the EP receptor subtypes mediating relaxation of the rabbit jugular and pig saphenous veins
1995 • 23 citations
Prostaglandin E2 Receptors on Human Peripheral Blood Monocytes
1985 • 23 citations
Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-α synthesis
1996 • 17 citations
Characterization of prostaglandin E2 receptors expressed on human monocytic leukaemic cell line, U937
1993 • 11 citations
Characterization of Thromboxane Receptors in Human Platelets
1985 • 10 citations